復星醫藥(02196.HK):為多家控股子公司提供擔保
格隆匯6月3日丨 復星醫藥(02196.HK)公佈,公司控股子公司蘇州二葉製藥有限公司(以下簡稱"蘇州二葉")擬為其控股子公司山東二葉向中國銀行股份有限公司菏澤分行(以下簡稱"中國銀行")申請的本金總額不超過人民幣7,000 萬元的融資債務提供最高額連帶責任保證擔保。
公司控股子公司上海復宏漢霖生物技術股份有限公司(以下簡稱"復宏漢霖")擬為其控股子公司漢霖製藥向上海浦東發展銀行股份有限公司長寧支行(以下簡稱"浦發銀行")申請的本金總額不超過等值人民幣 20,000 萬元的融資債務提供最高額連帶責任保證擔保。
公司擬為控股子公司復星實業向 Citibank N.A. Hong Kong Branch(以下簡稱"花旗銀行香港分行")申請的經調整貸款額度有效期後的本金總額不超過等值 8,500 萬美元的外幣貸款額度項下債務提供連帶責任保證擔保。
公司擬為控股子公司復星醫藥產業向花旗銀行(中國)有限公司上海分行(以下簡稱“花旗銀行上海分行”)申請的期限不超過 12 個月、本金總額不超過等值 6,000 萬美元的非承諾性短期循環融資項下債務提供連帶責任保證擔保。
公司擬為控股子公司復星醫藥產業向匯豐銀行(中國)有限公司上海分行(以下簡稱"匯豐銀行")申請的本金總額不超過等值人民幣 80,520 萬元額度項下債務提供連帶責任保證擔保。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.